Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial
Titel:
Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial
Auteur:
Gruenberger, T. Bridgewater, J. Chau, I. GarcĂa Alfonso, P. Rivoire, M. Mudan, S. Lasserre, S. Hermann, F. Waterkamp, D. Adam, R.